Sodium and volume excess is the fundamental risk factor underlying hypertension in chronic
kidney disease (CKD) patients, who represent the prototypical population characterized by …

Abstract Purpose of Review To perform a narrative systematic review on refractory
hypertension (RfHT) with particular emphasis on prognosis. Recent Findings There were 37 …

Background: There is continuous debate whether chlorthalidone (CTD) and
hydrochlorothiazide (HCTZ) differ in reducing major cardiovascular events (MACE). HCTZ is …

Hypertension is attributable long-term to various negative health outcomes, including
atherosclerotic cardiovascular disease and, more broadly, to cardiovascular events such as …

Background: Although thiazide diuretics are widely used for treating hypertension (HTN), the
comparative efficacy and safety of hydrochlorothiazide (HCTZ) versus chlorthalidone (CTD) …

Poorly controlled hypertension has been shown to be an independent risk factor for
cardiovascular disease, stroke, renal failure, and increased mortality. Angiotensin II receptor …

Hypertension is a global public health challenge, with a high prevalence across various
regions and significant implications for cardiovascular risk. This article reviews the …

Oral oncolytic treatment options have expanded over the last decade and have brought to
light the need to monitor and manage cardiovascular (CV) disease in patients being treated …

Background: Thiazide diuretics are currently the first-line treatment for hypertension (HTN).
This class of drugs includes hydrochlorothiazide (HCTZ) and the thiazide-like diuretic …

Доведено, що погано контрольована артеріальна гіпертензія (АГ) є незалежним
чинником ризику розвитку серцево-судинних захворювань, інсульту, ниркової …